Compare MBIN & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MBIN | AXGN |
|---|---|---|
| Founded | 1990 | N/A |
| Country | United States | United States |
| Employees | 735 | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.4B |
| IPO Year | N/A | 2013 |
| Metric | MBIN | AXGN |
|---|---|---|
| Price | $47.85 | $40.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $43.67 | $42.33 |
| AVG Volume (30 Days) | 186.3K | ★ 1.6M |
| Earning Date | 04-28-2026 | 04-28-2026 |
| Dividend Yield | ★ 0.89% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $225,208,000.00 |
| Revenue This Year | $31.76 | $20.57 |
| Revenue Next Year | $3.73 | $16.68 |
| P/E Ratio | $12.29 | ★ N/A |
| Revenue Growth | N/A | ★ 20.21 |
| 52 Week Low | $28.75 | $11.25 |
| 52 Week High | $51.47 | $46.95 |
| Indicator | MBIN | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 48.27 | 42.00 |
| Support Level | $48.08 | $39.65 |
| Resistance Level | $48.50 | $44.83 |
| Average True Range (ATR) | 1.35 | 2.67 |
| MACD | -0.35 | -0.47 |
| Stochastic Oscillator | 35.41 | 17.16 |
Merchants Bancorp is a United States-based bank holding company operating multiple lines of business focused on FHA multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. Its segments include Multi-family Mortgage Banking, which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing, which offers mortgage warehouse financing, commercial loans and deposit services; and the Banking segment, which generates maximum revenue and provides portfolio lending for multi-family and healthcare facility loans, residential mortgage banking, agricultural lending, SBA lending and community banking.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.